ACM
ARIA

Apex Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Apex Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$93K Sell
14,489
-23
-0.2% -$129 ﹤0.01% 263
2015
Q4 		$91K Hold
14,512
– – ﹤0.01% 246
2015
Q3 		$85K Sell
14,512
-6,233
-30% -$48K ﹤0.01% 252
2015
Q2 		$172K Buy
20,745
+1,100
+6% +$9.73K ﹤0.01% 258
2015
Q1 		$162K Sell
19,645
-558
-3% -$4.13K ﹤0.01% 247
2014
Q4 		$139K Buy
20,203
+4,379
+28% +$27.4K ﹤0.01% 250
2014
Q3 		$85K Buy
+15,824
New +$92.4K ﹤0.01% 242

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Apex Capital Management's ARIA Position: Q1 2016 in Review

Apex Capital Management reduced its Ariad Pharmaceuticals Inc (ARIA) stake by 0.16% in Q1 2016, selling an estimated $129 and leaving 14,489 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #263.

Apex Capital Management first reported a position in ARIA in Q3 2014 and has held it in 7 quarters since. The position peaked at $172K in Q2 2015. 162 funds tracked by Wall St. Rank hold ARIA as of Q1 2016.

  • Apex Capital Management held 14,489 shares of Ariad Pharmaceuticals Inc worth $93K as of Q1 2016.
  • Apex Capital Management sold 23 Ariad Pharmaceuticals Inc shares in Q1 2016, an estimated $129.
  • Ariad Pharmaceuticals Inc made up ﹤0.01% of Apex Capital Management's portfolio in Q1 2016, its #263 holding.
  • Apex Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and has held it in 7 quarters since.
  • Apex Capital Management's Ariad Pharmaceuticals Inc position peaked at $172K in Q2 2015.
  • 162 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.